Shots: Bluebird Bio to utilize its mRNA-based megaTAL technology providing a specific and efficient way to silence, edit or insert genetic components combining Novo Nordisk’s deep expertise in hemophilia research […]readmore
Tags : Three-year
Shots: Hitachi Chemical’s subsidiary HCATS (Hitachi Chemical Advanced Therapeutics Solutions), will manufacture GSK’s SPEAR T-cell receptor therapy targeting NY-ESO-1 for the US, Canadian and European trials The agreement focuses on […]readmore